Actively Recruiting
Tissue Study on the Chronic Active Humoral Rejection (cAMR) Population of Kidney Transplantation
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-27
50
Participants Needed
1
Research Sites
287 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is tissue-based, retrospective and prospective, single-centre, non-sponsored. Primary objective: To examine patient and organ survival and eGFR variation in kidney transplant patients diagnosed histologically with cAMR.
CONDITIONS
Official Title
Tissue Study on the Chronic Active Humoral Rejection (cAMR) Population of Kidney Transplantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Kidney transplant recipients
- eGFR greater than 15 ml/min/1.73 m² at time of cAMR diagnosis
- Diagnosis of chronic active humoral rejection (cAMR) based on 2018 Banff Classification, made after January 1, 2018
- Signed informed consent to participate in the study
You will not qualify if you...
- Patients who have received combined transplants (heart-kidney, liver-kidney, or kidney-pancreas)
- Evidence of other kidney diseases including recurrence of original nephropathy, new nephropathy, acute cellular rejection, polyomavirus BK nephropathy, or other histological diseases
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Sant'Orsola University Hospital - Nephrology, Dialysis and Transplant Unit
Bologna, BO, Italy, 40138
Actively Recruiting
Research Team
G
Gaetano La Manna, MD
CONTACT
G
Giorgia Comai, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here